The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBYOT.L Regulatory News (BYOT)

  • There is currently no data for BYOT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

1 Aug 2007 07:01

Byotrol PLC01 August 2007 Byotrol plc ("Byotrol" or "the Company") Directors' Shareholdings The Board of Byotrol announces that it has granted the following options toDirectors of the Company: 1. 50,000 options exercisable at 50p per share pursuant to the Byotrol Unapproved Share Option Scheme, to the Chairman, Wesley Devoto. 2. 100,000 options exercisable at 50p per share pursuant to the Byotrol Unapproved Share Option Scheme, to the Chief Executive, David McRobbie. 3. 100,000 options exercisable at 50p per share pursuant to the Byotrol Unapproved Share Option Scheme, to the Deputy Chairman, Stephen Falder. 4. 50,000 options exercisable at 50p per share pursuant to the Byotrol Unapproved Share Option Scheme, to the Finance Director, Richard Bell. 5. 50,000 options exercisable at 50p per share pursuant to the Byotrol Unapproved Share Option Scheme, to a Non-Executive Director, Ian Mainman. All options were granted by the remuneration committee on 31 July 2007. Alloptions are exercisable at any time between 31 July 2009 and 30 July 2017subject to the closing mid-market share price of Byotrol being not less than180p each business day for a consecutive period of three months. Following the grant of these options, the directors have the followinginterests: Number of Options Total Number of Shares % of issued share Existing % of issued share Granted Under Option capital shareholding capital Wesley Devoto 50,000 50,000 0.11% 424,200 0.97%David McRobbie 100,000 325,000 0.74% 3,647,614 8.40%Stephen Falder 100,000 325,000 0.74% 4,787,757 11.03%Richard Bell 50,000 100,000 0.23% 10,000 0.02%Ian Mainman 50,000 50,000 0.11% 303,000 0.69% Enquiries: Byotrol plc 0161 277 9518 Richard Bell Finance Director 07825 204110 Charles Stanley Securities 020 7149 6457 Philip Davies / Anthony Noakes This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
30th Apr 20247:00 amRNSCancellation - Byotrol Plc
29th Apr 20242:15 pmRNSSecondary Trading on Asset Match
23rd Apr 20246:00 pmRNSByotrol
22nd Apr 20244:44 pmRNSCapital Reorganisation Delay
22nd Apr 20241:27 pmRNSResults of General Meeting
15th Apr 202411:48 amRNSHolding(s) in Company
8th Apr 20247:00 amRNSHolding(s) in Company
2nd Apr 20243:27 pmRNSDirector Dealing
28th Mar 20247:00 amRNSProposed Cancellation
22nd Dec 202311:44 amRNSHolding(s) in Company
7th Dec 20237:00 amRNSHalf-year Report
14th Nov 20237:00 amRNSLaunch of PROCESSUS® Instrument Decontamination
14th Nov 20237:00 amRNSTrading Update
9th Nov 20233:43 pmRNSHolding(s) in Company
27th Sep 20237:00 amRNSBoard Changes
13th Sep 20233:33 pmRNSResult of AGM
8th Sep 20234:33 pmRNSDirector Dealing
7th Sep 20237:01 amRNSBoard Appointment
7th Sep 20237:00 amRNSTrading Update
29th Aug 20238:51 amRNSLaunch of CHEMGENE MEDLAB into human healthcare
23rd Aug 20237:00 amRNSInvestor Presentation via Investor Meet Company
31st Jul 20237:00 amRNSFinal Results
6th Jul 20237:00 amRNSPatent Grant for Novel Anti-viral Seaweed Extract
24th May 20233:14 pmRNSUS EPA approves Byotrol24 as long-lasting virucide
24th May 20238:51 amRNSDirector Dealing
28th Apr 20239:57 amRNSDirector Dealing
27th Apr 20237:00 amRNSTrading Update and Board Changes
1st Feb 20239:52 amRNSDirector Dealing
22nd Dec 20223:08 pmRNSDirector Dealing
19th Dec 202210:00 amRNSDirector Dealing
16th Dec 20227:00 amRNSGrant of Share Incentive Awards
12th Dec 20227:00 amRNSInterim results and Investor Presentation
22nd Nov 20227:00 amRNSDirectorate Changes
27th Sep 202211:15 amRNSPDMR Shareholding
22nd Sep 20225:21 pmRNSResult of AGM
8th Sep 20227:00 amRNSDirector Dealing
2nd Sep 202210:02 amRNSInvestor Presentation
30th Aug 20227:00 amRNSFinal Results
12th Aug 20223:30 pmRNSDirector Dealing
28th Jul 20227:00 amRNSCompletion of Convertible Loan Note Fundraising
11th Jul 20227:00 amRNSTrading Update and Notice of Results
22nd Apr 20229:14 amRNSHolding(s) in Company
2nd Mar 20227:00 amRNSTrading Update
12th Jan 20227:00 amRNSSenior Management Appointment
14th Dec 20219:06 amRNSSecond Price Monitoring Extn
14th Dec 20219:00 amRNSPrice Monitoring Extension
13th Dec 20217:00 amRNSDirectorate Change
9th Dec 20218:51 amRNSDirector Dealing
8th Dec 20217:00 amRNSInterim Results and Investor Presentation
2nd Nov 20217:00 amRNSDirectorate and Senior Management Changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.